Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Kentucky - United States Doctors can start recommending medical cannabis to patients next month ...
  • Uruguay Presidential frontrunners unlikely to change cannabis legislation ...
  • Europe Agreement on EC make-up could include cannabis-conservative health commissioner ...
  • Ukraine New additions to list of prohibited psychotropic substances ...
  • Germany BfArM published medical cannabis import data for for Q3 2024 ...
  • Denmark Government plans to make medical cannabis scheme permanent ...
  • United States Senate committee releases Farm Bill draft ...
  • Luxembourg Medical cannabis patients to see restrictions in 2025 ...
  • Moldova Passed amendment allows for registered hemp varieties to be cultivated ...
  • Germany Cannabis legalisation debate takes place ahead of snap elections ...
  • Ireland Ruling parties disagree on proposal to decriminalise personal drug use ...
  • Brazil Up to 0.3% THC in plants authorised for medical, pharmaceutical, industrial use ...
View all
Blogs

Do companies need toxicological study data included in UK Food Standards Agency (FSA) novel food applications for them to be validated?

Written by || 9th October 2020 || Blogs | Food | Health and science | Policy and Politics | Regulation and legislation | Technology and innovation | GeographiesEurope United Kingdom

There are still quite a few unanswered questions regarding the novel food application process under the FSA. Fortunately the requirement of having toxicological data
Read more
I'm already a subscriber

Login

Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Related open content
Is another Donald Trump administration bad news for the US cannabis industry?
Tamarind Intelligence podcast: Impact of novel nicotine products on public tobacco firms
Cannabis and the US elections: from Schedule I drug to business prospect

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.